Yubo International Biotech Ltd
YBGJ· OTC
YBGJYubo International Biotech Ltd
Filed Mar 31, 2025 · 10-K · 90 days after period end · 0001640334-25-000547
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $18.12K | $66.52K | — |
| Net Income | -$352.89K | -$517.38K | $103.61K | -$397.17K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end
